Deep Learning Enabled Electrocardiogram Aimed to Detect Coronary Artery Disease to Predict Atherosclerotic Cardiovascular Events in the Community
Abstract Body (Do not enter title and authors here): Background: We previously developed deep-learning algorithms that identify coronary artery disease (CAD) risk based on (i) coronary artery calcium (CAC), (ii) obstructive CAD by angiography, and (iii) left ventricular akinesis in ≥1 segment by echocardiogram, using a 12-lead electrocardiogram (CAD ECG-AI). We tested the hypothesis that those with increased probability of CAD by CAD ECG-AI algorithms will have an increased risk of atherosclerotic cardiovascular disease (ASCVD) events and would refine the AHA Predicting Risk of Cardiovascular Disease Events (PREVENTTM) equations’ predictive capabilities.
Methods: We assessed a group of consecutive patients who sought primary care in Olmsted County, MN, between 1997 and 2003. Passive follow-up was conducted using the Rochester Epidemiology Project's record linkage system. Patients included met the same criteria of the original PREVENTTM equations. The probability output of each CAD ECG-AI algorithm was used to predict ASCVD (fatal and non-fatal myocardial infarction and ischemic stroke) and ASCVD-Plus [further including percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and all-cause mortality]. Events were validated in duplicate. Cox proportional hazard models adjusted for age, sex, and risk factors while modeling each CAD ECG-AI algorithm as an individual and additive predictor (see footnote). PREVENTTM risk categories stratified analysis to evaluate the effect of the CAD ECG-AI models on predicted ASCVD risk.
Results: We included 21,193 patients, with mean ± SD age 51.6 ± 12.0, 54% women and 95% white. After 14.2±12.4 years follow-up, 1,351 (6.4%) developed ASCVD, and 2,808 (13.2%) had ASCVD-Plus. The risk of ASCVD and ASCVD-Plus increased with positivity for the CAD ECG-AI algorithms after adjustments for age, sex, and PREVENTTM equations factors, all p for trend <0.001 (data not shown). In additive analyses, the risk of ASCVD and ASCVD-Plus increased with increased CAD ECG-AI factors, all p for trend <0.001 (Fig. A-B). Furthermore, the CAD ECG-AI algorithm enhanced the predictive capabilities of PREVENTTM equations across most risk subgroups (Fig. C-E).
Conclusions: The deep-learning CAD ECG-AI algorithms displayed an independent and additive association with long-term ASCVD and ASCVD-Plus events in the community and improved the PREVENTTM predicted ASCVD risk. The CAD ECG-AI algorithms could help identify individuals at risk in primary prevention of cardiovascular events.
Medina-inojosa, Jose
( MAYO CLINIC
, Rochester
, Minnesota
, United States
)
Mangold, Kathryn
( Mayo Clinic
, Rochester
, Minnesota
, United States
)
Awasthi, Samir
( Anumana
, Boston
, Massachusetts
, United States
)
Medina-inojosa, Betsy
( Mayo Clinic
, Rochester
, Minnesota
, United States
)
Mccully, Robert
( Mayo Clinic
, Rochester
, Minnesota
, United States
)
Lerman, Amir
( Mayo Clinic
, Rochester
, Minnesota
, United States
)
Attia, Zachi
( Mayo Clinic
, Rochester
, Minnesota
, United States
)
Friedman, Paul
( MAYO CLINIC
, Rochester
, Minnesota
, United States
)
Lopez-jimenez, Francisco
( MAYO CLINIC COLL MEDICINE
, Rochester
, Minnesota
, United States
)
Author Disclosures:
Jose Medina-Inojosa:DO NOT have relevant financial relationships
| Kathryn Mangold:DO NOT have relevant financial relationships
| Samir Awasthi:No Answer
| Betsy Medina-Inojosa:DO NOT have relevant financial relationships
| Robert McCully:No Answer
| Amir Lerman:DO NOT have relevant financial relationships
| Zachi Attia:DO have relevant financial relationships
;
Consultant:Anumana:Active (exists now)
; Consultant:Eko:Active (exists now)
; Consultant:AliveCor:Active (exists now)
; Ownership Interest:XAI.health:Active (exists now)
| Paul Friedman:DO NOT have relevant financial relationships
| Francisco Lopez-Jimenez:DO have relevant financial relationships
;
Employee:Mayo Clinic:Active (exists now)
; Advisor:Select Research:Active (exists now)
; Advisor:WizeCare:Active (exists now)
; Consultant:Kento Health:Active (exists now)
; Advisor:Novo Nordisk:Active (exists now)
Hasabo Elfatih A., Sultan Sherif, Soliman Osama, A. Aboali Amira, Hemmeda Lina, Salah Alaa, Alrawa Salma S., Elgadi Ammar, Abdalmotalib Malaz, Yasir H Eissa Abdullatif, Mahmmoud Fadelallah Eljack Mohammed